logo
  • Global Challenge
  • Our Approach
  • Partnering
  • Pipeline
  • Join Us
  • News & Events
  • Investors
    • Company Information
    • Board and Management
    • Advisors
    • Investor Alert
  • Publications
  • Contact

World Antibiotic Awareness Week Video

November 18, 2019
|In Alderley Park, News, Publications
|By Carl Curran

 

 

  • Prev
  • All Stories
  • Next

Related News

CARB-X Receives Additional $370m from U.S. Government and Wellcome

Enables continued investment in innovative projects to tackle the growing global threat…

Breaking News

Infex Therapeutics to begin clinical development of anti-virulence therapy for Pseudomonas aeruginosa (Pa) in non-cystic fibrosis bronchiectasis patients

MHRA grants approval of Phase 1 clinical trial, expected to start in H2 2022

Press Releases,Breaking News,Pipeline

Infex welcomes NICE and NHS England’s new antibiotic reimbursement mechanism

Infex Therapeutics, one of the UK’s leading infectious disease biotech companies, has…

Press Releases,Breaking News

Infex scientists achieve breakthrough to overcome critical priority drug resistant infections

One of the UK’s leading infectious disease biotech companies has announced a breakthrough…

Press Releases,Breaking News,Pipeline

Infex agrees partnership with Colibri Scientific to provide services for RESP-X program

Infex Therapeutics has today announced a deal with Colibri Scientific, to provide…

Press Releases,Alderley Park,Breaking News

Infex scientists achieve breakthrough with potential new drug for Omicron and new coronavirus strains

One of the UK’s leading infectious disease biotech companies has announced a breakthrough…

Press Releases,Breaking News,Pipeline

Budget’s R&D investment increase must propel action on AMR, says Dr Peter Jackson of Infex Therapeutics

“The announcement today that the government is increasing public R&D investment to record…

Press Releases,Breaking News

Infex Therapeutics sharpens Covid focus with new CRUK Newcastle partnership

Infex Therapeutics is pressing ahead with a major development of its pandemic resilience…

Press Releases,Breaking News,Pipeline

Tackling underlying respiratory conditions for this pandemic and next

During the COVID-19 pandemic, one of the many phrases that has become irreversibly etched…

Press Releases,Breaking News

© Infex Therapeutics Ltd. All rights reserved.